Organization · Venture Capital
Oklahoma Life Science Fund
The Oklahoma Life Science Fund (OLSF) is an early-stage venture capital fund based in Tulsa, Oklahoma, focusing on health care and life sciences investments. Since 2000, it has supported local startups in therapeutics, medical devices, and diagnostics.
Overview
What Oklahoma Life Science Fund does
What Oklahoma Life Science Fund is
The Oklahoma Life Science Fund (OLSF) is an early-stage venture capital fund based in Tulsa, Oklahoma, focusing on health care and life sciences investments. Since 2000, it has supported local startups in therapeutics, medical devices, and diagnostics.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2000
- Approximate age
- About 26 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Oklahoma Life Science Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
Oklahoma Life Science Fund as a funder
Investment thesis
OLSF invests in promising life science technologies where businesses and management teams can be built. The firm expects to be the first professionally managed money invested, remaining active by shaping strategy, assuring capitalization, and driving execution.
Focus narrative
OLSF invests in early-stage companies within the health care and life sciences sectors, specifically targeting therapeutics, medical devices, diagnostics, and technology-enabled services. The fund emphasizes its commitment to companies based in Oklahoma and the surrounding regions, fostering local innovation and growth.
Value beyond capital
OLSF adds value to its portfolio companies through active involvement in strategy, capitalization, and execution. The fund aims to build strong management teams around promising technologies, ensuring that companies are well-positioned for growth and success in the competitive health care and life sciences landscape.
Focus and fit
- Stages
- Seed · Series A · Accelerator
- Sectors
- Healthcare · Biotech · Medical Devices · Diagnostics
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Selexys Pharmaceuticals, Care ATC, and Inoveon
Portfolio context
Notable portfolio companies include: Sway: Develops smartphone applications for cognitive testing. Recuro Health: Provides an integrated digital health solution. Zero: A mobile benefit plan manager. Otologic Pharmaceutics: Focuses on therapeutic solutions for hearing health. Tetherex Pharmaceuticals: Developing a treatment for Crohn's disease. AliveCor: Offers a smartphone-enabled electrocardiogram (ECG) device. Selexys Pharmaceuticals: Acquired by Novartis, focused on treatments for sickle cell disease.
Common questions
What to know about Oklahoma Life Science Fund
Upseed classifies Oklahoma Life Science Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.